e-learning
resources
Munich 2006
Monday 04.09.2006
Pulmonary gas exchange
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease
R. Ergun, D. Ergun, S. Ardic, C. Ozdemir, M. Altinors, H. Firat, G. Darilmaz Yuce, M. B. Yuceege (Ankara, Turkey)
Source:
Annual Congress 2006 - Pulmonary gas exchange
Session:
Pulmonary gas exchange
Session type:
Thematic Poster Session
Number:
2399
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Ergun, D. Ergun, S. Ardic, C. Ozdemir, M. Altinors, H. Firat, G. Darilmaz Yuce, M. B. Yuceege (Ankara, Turkey). The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease. Eur Respir J 2006; 28: Suppl. 50, 2399
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 963-965
Year: 2014
Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 269-274
Year: 2005
Exhaled carbon monoxide in pulmonary sarcoidosis: clinical correlations
Source: Eur Respir J 2005; 26: Suppl. 49, 79s
Year: 2005
Increased levels of exhaled carbon monoxide and their correlation with airflow obstruction in asthma and COPD
Source: Annual Congress 2012 - Tobacco dependence and respiratory disease
Year: 2012
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 439-443
Year: 2003
Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005
Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
The importance of measuriing exhaled carbon monoxide in asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 82s
Year: 2003
Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2007; 29: 944-950
Year: 2007
Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study
Source: Eur Respir J 2007; 30: 1131-1137
Year: 2007
Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005
Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients
Source: Eur Respir J 2011; 39: 119-124
Year: 2012
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients
Source: Eur Respir J 2012; 39: 119-124
Year: 2012
Effect of salbutamol on arterial blood gas tensions in patients with stable hypercapnic chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 16s
Year: 2004
Exhaled carbon monoxide (CO) as an index of monitoring inflammation in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 423s
Year: 2002
Non-invasive monitoring of carbon dioxide levels in patients using non-invasive ventilation for acute exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 549s
Year: 2005
Arterial blood gases during exercise in chronic obstructive pulmonary disease with and without pulmonary hypertension
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Noninvasive positive pressure ventilation using helium:oxygen versus air:oxygen in acute respiratory failure in chronic obstructive pulmonary disease patients exposed to sulfur mustard
Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions
Year: 2008
Values of diffusing capacity for carbon monoxide (DLco) in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease – (overlap syndrome)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept